Skip to main content

Table 4 The association between KCF-S “SKELETON C5a(N1b+O5a)-C1c(N1b)-C1b-C8y-C8x-C8x-C8x-C8x-C8x” and KEGG pathway “hsa03050 Proteasome”

From: Network-based characterization of drug-protein interaction signatures with a space-efficient approach

KCF-S

SKELETON C5a(N1b+O5a)-C1c(N1b)-C1b-C8y-C8x-

 

C8x-C8x-C8x-C8x

Pathway

hsa03050 Proteasome

Drug

D00284 Cosyntropin (hormone, adrenocorticotropic)

 

D02108 Indium In 111 pentetreotide (radioactive agent)

 

D03150 Bortezomib (anticancer, proteasome inhibitor)

 

D08880 Carfilzomib (anticancer, proteasome inhibitor)

Protein

hsa:3458 interferon gamma

 

hsa:5682 - hsa:5688 20S proteasome subunit alpha 1-7

 

hsa:5689 - hsa:5699 20S proteasome subunit beta 1-10

 

hsa:5707, hsa:5708, hsa:5713 26S proteasome regulatory subunit N1, N2, N8

  1. See also Fig. 6